We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rare Neurodegenerative Disorders Share DNA Repeat Mutation

By LabMedica International staff writers
Posted on 29 Jul 2019
Genomics researchers have found that at least four rare neurodegenerative diseases result from CGG (cytosine-guanine-guanine) repeat mutations the DNA located in distant, seemingly unrelated areas of the genome.

Noncoding repeat expansions cause various neuromuscular diseases, including myotonic dystrophies, fragile X tremor/ataxia syndrome, some spinocerebellar ataxias, amyotrophic lateral sclerosis, and benign adult familial myoclonic epilepsies.

Inspired by the striking similarities in the clinical and neuroimaging findings between neuronal intranuclear inclusion disease (NIID) and fragile X tremor/ataxia syndrome caused by noncoding CGG repeat expansions in the FMR1 (fragile X mental retardation 1) gene, investigators at the University of Tokyo (Japan) used advanced next-generation genome sequencing and data analysis techniques to search directly for repeat expansion mutations.

Results of the DNA sequencing study identified noncoding CGG repeat expansions in the NBPF19 (Neuroblastoma breakpoint family member 19) gene as the causative mutations for NIID. More...
NIID is a slowly progressive, neurodegenerative disease that may affect any part of the nervous system (central, peripheral, and/or autonomic), as well as various organs. The features of NIID result from the presence of eosinophilic intranuclear inclusions inside neurons and glial cells. Both sporadic and familial cases have been reported. However, specific genes known to cause NIID had not previously been found.

Further prompted by the similarities in the clinical and neuroimaging findings with NIID, the investigators identified similar noncoding CGG repeat expansions in two other diseases: oculopharyngeal myopathy with leukoencephalopathy and oculopharyngodistal myopathy.

"Because the mutations causing the diseases are so similar, in the future, all these patients might benefit from the same treatment," said first author Dr. Hiroyuki Ishiura, an assistant professor at the University of Tokyo Hospital.

The study was published in the July 22, 2019, online edition of the journal Nature Genetics.

Related Links:
University of Tokyo


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
PSA Assay
CanAg PSA EIA
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.